For CDH11 loss-of-function studies, we used On-Target plus Human CDH11 siRNA-Smart pool (L-013493-00-0005, Dharmacon, Lafayette, CO, US) that contains 4 siRNA mix. CDH11 #1: 5’-GUGAGAACAUCAUUACUUA-3’. CDH11 #2: 5’-GGACAUGGGUGGACACAUAUG-3’. CDH11 #3: 5’-GGAAAUAGCGCCAAGUUAG-3. CDH11 #4: 5’-CCUUAUGACUCCAUUCAAA-3’. A day before transfection, MDA-MB-231 cell line was seeded into 6-well cell plate at a density of 3 × 105 cells/well in DMEM containing 10% FBS without antibiotics. The Hs578t cell line was seeded in the same condition except the density (2 × 105 cells/well). After 24 hours incubation, 30–40% confluent cells were transfected with siRNA using Lipofectamine 3000 (L3000008, Thermo Fisher Scientific, Waltham, MA, USA) in serum-free DMEM. 80 nM of siRNA was used as final concentration. Six hours after initial transfection, the medium was replaced with fresh DMEM containing 10% FBS. Next day, cells were re-transfected with same siRNA, following same transfection steps. The siRNA-transfected cells were incubated for 48 h since the first transfection and used for western blot, and functional assays.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.